Success Stories: NAILG Fast-Tracks EB-1A Approval in Just 19 Days for Doctor in Rehabilitation Medicine
Client’s Testimonial:
“Thank you so much for your help throughout the whole process. You are always helpful and efficient, and I hope your firm will continue to be successful in the future.”
On May 12th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Doctor in the Field of Medical Research (Approval Notice).
General Field: Medical Research
Position at the Time of Case Filing: Doctor
Country of Origin: Taiwan
Country of Residence at the Time of Filing: Taiwan
Approval Notice Date: May 12th, 2025
Processing Time: 19 days (Premium Processing Requested)
Case Summary:
When our client sought NAILG’s assistance, it was clear that his pioneering research in rehabilitation medicine and postoperative pain management was of national significance. Specializing in opioid dependency and pain management for surgical patients, our client has developed innovative methods that aim to tackle some of healthcare's most pressing issues, high analgesic consumption, adverse side effects like nausea and vomiting, and extended recovery times. His work in pain relief and post-surgery care is transforming medical approaches and improving patient outcomes.
His proposed endeavor focuses on advanced pain management strategies for cancer patients and orthopedic surgery recovery, with notable contributions to the use of robot-assisted pedicle screw insertions. His research has also made significant strides in understanding how to assess mental states in colorectal cancer patients, a crucial area of holistic healthcare that ensures better overall care for those suffering from severe diseases.
Our client’s academic impact is undeniable:
● 9 peer-reviewed journal articles, including 6 first-authored
● 423 citations of his research, placing him among the top 1% most highly cited authors in musculoskeletal pain over the past 7 years
● 15 peer reviews conducted, reflecting his recognized authority in the field of rehabilitation medicine
One expert wrote the following in support of our client’s research:“To sum up, [client] has tackled postoperative pain management and opioid dependency in surgical patients, including the challenges of high analgesic consumption, adverse effects like nausea and vomiting, and prolonged recovery times through his important research. His remarkable work, as well as his participation in the peer review process, establishes [client] as a uniquely valuable figure in the field of medical research.”
NAILG worked with our client to ensure his EB-1A petition was presented with the full weight of its national significance. From the outset, we carefully framed his work in pain management and rehabilitation medicine to demonstrate its real-world impact on improving patient outcomes, particularly in surgical recovery and cancer treatment. Our team’s attention to detail and strategic approach led to a successful EB-1A approval, enabling our client to continue advancing his work without delay.We are proud that our client chose NAILG to guide him through this important journey, and we look forward to seeing the continued impact of his innovative research in medical advancements and patient care.